Literature DB >> 2078293

Could specific oral tolerance be a therapy for autoimmune disease?

H S Thompson1, N A Staines.   

Abstract

Several experimental autoimmune diseases have been successfully suppressed by the induction of specific oral tolerance. Here, Stephen Thompson and Norman Staines review the nature and mechanisms of this form of tolerance and discuss its possible applications in the control of human autoimmune diseases.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2078293     DOI： 10.1016/0167-5699(90)90158-6

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  22 in total

Review 1.  Oral tolerance and gut-oriented immune response to dietary proteins.

Authors:  O Alpan
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

2.  Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

Authors:  J B Sun; C Rask; T Olsson; J Holmgren; C Czerkinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 3.  Current and future therapies for myasthenia gravis.

Authors:  Q Yi; A K Lefvert
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

4.  Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance.

Authors:  J B Sun; J Holmgren; C Czerkinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

Review 5.  Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease.

Authors:  P J Fairchild; C J Thorpe; P J Travers; D C Wraith
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

Review 6.  Oral tolerance in disease.

Authors:  P Garside; A M Mowat; A Khoruts
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

Review 7.  Experimental animal models resembling rheumatoid arthritis.

Authors:  P M Kaklamanis
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

8.  Prostanoids as friends, not foes: further evidence from the interference by cycloxygenase-inhibitory drugs when inducing tolerance to experimental arthritigens in rats.

Authors:  Michael W Whitehouse
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

Review 9.  Strategies for preventing type I diabetes mellitus.

Authors:  C F Verge; G S Eisenbarth
Journal:  West J Med       Date:  1996-03

10.  Identification and characterization of a major tolerogenic T-cell epitope of type II collagen that suppresses arthritis in B10.RIII mice.

Authors:  H Miyahara; L K Myers; E F Rosloniec; D D Brand; J M Seyer; J M Stuart; A H Kang
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.